Literature DB >> 14208196

STUDIES ON THE HYPERGLYCAEMIA INDUCED BY CHLORPROMAZINE IN RATS.

A BONACCORSI, S GARATTINI, A JORI.   

Abstract

Chlorpromazine induces in rats a marked and long-lasting hyperglycaemia which (a) is more marked at low than high room temperatures, (b) is inhibited by phentolamine but not by dibenamine, and (c) is prevented by adrenalectomy, by removal of the adrenal medullae and by treatment of the rats with reserpine. Other experimental results suggest that there is a correlation between the hyperglycaemia and the hypothermia induced by chlorpromazine and by its congeners. The hyperglycaemia seems to be the result of at least two factors: an activation of the adrenergic mechanisms and an impaired peripheral utilization of glucose.

Entities:  

Keywords:  ADRENAL MEDULLA; ADRENALECTOMY; CHLORPROMAZINE TOXICOLOGY; DIBENAMINE; EXPERIMENTAL LAB STUDY; GLUCOSE METABOLISM; HYPERGLYCEMIA; INJECTIONS, INTRAPERITONEAL; PHARMACOLOGY; PHENTOLAMINE; RATS; RESERPINE; SYMPATHOLYTICS; TEMPERATURE; THIORIDAZINE; TRIFLUPROMAZINE

Mesh:

Substances:

Year:  1964        PMID: 14208196      PMCID: PMC1703947          DOI: 10.1111/j.1476-5381.1964.tb01570.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  18 in total

1.  [Inhibition of the hypoglycemic effect of rastinon by megaphen and its elimination by pendiomide].

Authors:  M HUDEPOHL; K LEDERBOGEN
Journal:  Klin Wochenschr       Date:  1963-03-01

2.  Effects of chlorpromazine and epinephrine on blood-sugar of rabbits.

Authors:  S K GUPTA; M A PATEL; A D JOSEPH
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-10-01

3.  The influence of chlorpromazine on intermediary carbohydrate metabolism.

Authors:  A S MORACZEWSKI; K P DU BOIS
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-06-01

4.  [Influence of the environmental temperature on the rectal temperature of the rat treated with some phenothiazine derivatives].

Authors:  P BINET; J DECAUD
Journal:  Therapie       Date:  1960       Impact factor: 2.070

5.  Chlorpromazine protection against alloxan diabetes.

Authors:  M S SIMOES; W OSSWALD
Journal:  Metabolism       Date:  1955-07       Impact factor: 8.694

6.  Glycemic effects of chlorpromazine in the mouse, hamster and rat.

Authors:  D NORMAN; W A HIESTAND
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

7.  [Effect of chlorpromazine on various actions of adrenalin & noradrenalin in the dog].

Authors:  J DELGA; R HAZARD
Journal:  Arch Int Pharmacodyn Ther       Date:  1957-02-01

8.  Dibenamine blockade of epinephrine and glucagon hyperkalemias.

Authors:  S ELLIS; S B BECKETT; J H BOUTWELL
Journal:  Proc Soc Exp Biol Med       Date:  1957-02

9.  [Effect of temperature on pharmacological effect of chlorpromazine].

Authors:  T BERTI; L CIMA
Journal:  Arch Ital Sci Farmacol       Date:  1954-07

10.  Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues.

Authors:  J AXELROD; L G WHITBY; G HERTTING
Journal:  Science       Date:  1961-02-10       Impact factor: 47.728

View more
  10 in total

1.  The action of salicylate in reducing plasma free fatty acids and its pharmacological consequences.

Authors:  A Bizzi; S Garattini; E Veneroni
Journal:  Br J Pharmacol Chemother       Date:  1965-08

2.  Blood glucose, serum GOT and tissue catecholamines in rats after combined ethanol-tranquilizer administration.

Authors:  H Vapaatalo; H Karppanen
Journal:  Agents Actions       Date:  1970-08

3.  Hypothermic action of chlorpromazine in monkeys.

Authors:  C Y Chai; Y D Fann; M T Lin
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

4.  Hypoglycaemic coma occurring during treatment with chlorpromazine and orphenadrine.

Authors:  R M Buckle; J Guillebaud
Journal:  Br Med J       Date:  1967-12-09

5.  [Influence of psychopharmacologic agents on the nonesterified fatty acids in blood plasma].

Authors:  K Optiz
Journal:  Experientia       Date:  1965-08-15

6.  A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.

Authors:  John W Newcomer; Robert E Ratner; Jan W Eriksson; Robin Emsley; Didier Meulien; Frank Miller; Julia Leonova-Edlund; Ronald W Leong; Martin Brecher
Journal:  J Clin Psychiatry       Date:  2009-04-07       Impact factor: 4.384

7.  Effects of psychotropic drugs on canine cerebral metabolism and circulation related to EEG--diazepam, clomipramine, and chlorpromazine.

Authors:  A Sari; Y Fukuda; T Sakabe; T Maekawa; T Ishikawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-09       Impact factor: 10.154

8.  Propranolol and blood glucose: simultaneous measurements over a wide range of doses and the effect of propranolol on the glucose tolerance test.

Authors:  D H Staniforth; N J Yorkston; M Gemidjioglu
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

9.  Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules.

Authors:  O Ferraris; M Moroso; O Pernet; S Emonet; A Ferrier Rembert; G Paranhos-Baccalà; C N Peyrefitte
Journal:  Antiviral Res       Date:  2015-03-20       Impact factor: 5.970

Review 10.  Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences.

Authors:  Marco Carli; Shivakumar Kolachalam; Biancamaria Longoni; Anna Pintaudi; Marco Baldini; Stefano Aringhieri; Irene Fasciani; Paolo Annibale; Roberto Maggio; Marco Scarselli
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.